R S Elkeles

Author PubWeight™ 69.43‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Attitudes of consultant physicians to the Calman proposals: a questionnaire survey. North West Thames Diabetes and Endocrinology Specialist Group. BMJ 1995 4.77
2 High prevalence of gestational diabetes in women from ethnic minority groups. Diabet Med 1992 1.66
3 Variation in the PPARalpha gene is associated with altered function in vitro and plasma lipid concentrations in Type II diabetic subjects. Diabetologia 2000 1.54
4 Effect of oestrogens on human platelet behaviour. Lancet 1968 1.49
5 The effects of metformin on glycemic control and serum lipids in insulin-treated NIDDM patients with suboptimal metabolic control. Diabetes Care 1998 1.28
6 Effect of treatment of hyperlipidaemia on haemostatic variables. Br Med J 1980 1.20
7 Effects of smoking on oral fat tolerance and high density lipoprotein cholesterol. Clin Sci (Lond) 1983 1.18
8 Factors predisposing to and outcome of gestational diabetes. Obstet Gynecol 1989 1.10
9 Smoking is associated with increased hepatic lipase activity, insulin resistance, dyslipidaemia and early atherosclerosis in Type 2 diabetes. Atherosclerosis 2001 1.06
10 Hypoglycaemia in an inner-city accident and emergency department: a 12-month survey. Arch Emerg Med 1989 1.04
11 Impaired intravascular lipolysis with changes in concentrations of high density lipoprotein subclasses in young smokers. Br Med J (Clin Res Ed) 1987 1.03
12 Serum lipids, lipoproteins and macrovascular disease in non-insulin-dependent diabetics: a possible new approach to prevention. Diabet Med 1988 1.00
13 The effect of diet and insulin on metabolic profiles of women with gestational diabetes mellitus. Diabetes 1985 0.99
14 The effect of heparin in vitro on human plasm post-heparin lipolytic activity. Clin Chim Acta 1975 0.95
15 Prevalence of renal artery stenosis in subjects with type 2 diabetes and coexistent hypertension. Diabetes Care 2000 0.93
16 Effect of a pyrimido-pyrimidine compound on platelet behaviour in vitro and in vivo. Lancet 1968 0.92
17 The role of insulin insensitivity and hepatic lipase in the dyslipidaemia of type 2 diabetes. Diabet Med 1991 0.90
18 Total antioxidant status and coronary artery calcification in type 1 diabetes. Diabetes Care 2001 0.90
19 Alpha-blocker therapy; a possible advance in the treatment of diabetic hypertension--results of a cross-over study of doxazosin and atenolol monotherapy in hypertensive non-insulin dependent diabetic subjects. J Hum Hypertens 1990 0.89
20 Effect of treatment of hypertriglyceridaemia on high and low density lipoprotein cholesterol concentrations. Lancet 1979 0.87
21 High-density lipoprotein composition and paraoxonase activity in Type I diabetes. Clin Sci (Lond) 2001 0.87
22 Evidence for an hepatic anti-ketogenic effect of insulin in man. Clin Sci Mol Med 1978 0.86
23 Calorie restriction for treatment of gestational diabetes. Diabetes 1991 0.85
24 Beta-blockers, lipoproteins and non-insulin dependent diabetes. Postgrad Med J 1988 0.85
25 Type 2 diabetes presenting as diabetic ketoacidosis in adolescence. Diabet Med 2003 0.84
26 Heroin and hyperkalaemia. Lancet 1981 0.84
27 The effect of insulin on adenosine 3':5'-monophosphate and guanosine 3':5'-monophosphate concentrations in human plasma. Clin Sci Mol Med 1976 0.84
28 Serum-insulin in acromegaly. Lancet 1969 0.83
29 Lipoprotein lipase in human adipose tissue. Clin Sci Mol Med 1974 0.82
30 Lipids in non-insulin dependent diabetes: a case for treatment? J R Soc Med 1991 0.82
31 The effect of glibenclamide and metformin on serum lipoproteins in type 2 diabetes. Diabet Med 1988 0.82
32 Arterial wall changes in type 2 diabetic subjects. Diabet Med 1994 0.82
33 Prostaglandin E 1 and human platelets. Lancet 1969 0.81
34 Total antioxidant status, protein glycation, lipid hydroperoxides in non insulin dependent diabetes mellitus. Biochem Soc Trans 1997 0.81
35 Can protein biomarkers provide an index of coronary artery calcification in patients with Type 2 diabetes? Atherosclerosis 2010 0.81
36 Abnormalities of glucose tolerance following gestational diabetes. Q J Med 1990 0.81
37 Lipid modification and coronary heart disease in type 2 diabetes: different from the general population? Heart 1999 0.81
38 High density lipoproteins, diabetes and diabetic macrovascular disease. Diabet Med 1985 0.80
39 Rates of cholesterol esterification and esterified cholesterol net mass transfer between high-density lipoproteins and apolipoprotein B-containing lipoproteins in Type 1 diabetes. Diabet Med 2002 0.80
40 Hepatic and lipoprotein lipases selectively assayed in postheparin plasma. Clin Chem 1993 0.80
41 Correlation between carotid artery distensibility and serum vascular endothelial growth factor concentrations in type 1 diabetic subjects and nondiabetic subjects. Metabolism 2001 0.79
42 Plasma adenosine 3':5'-cyclic monophosphate response to glucagon in thyroid disease. Clin Sci Mol Med 1975 0.79
43 The effect of hypolipidaemic therapy on serum uric acid concentration. Atherosclerosis 1976 0.78
44 Diabetic hypertension--the importance of fibrinogen and blood viscosity. J Hum Hypertens 1988 0.78
45 The effects of chlorpropamide and insulin on serum lipids, lipoproteins and fractional triglyceride removal. Diabetologia 1978 0.78
46 The relationship between active renin concentration and plasma renin activity in Type 1 diabetes. Diabet Med 2001 0.78
47 The effects of fasting and streptozotocin diabetes on hepatic triglyceride lipase activity in the rat. Diabetes 1977 0.78
48 Coronary calcification, homocysteine, C-reactive protein and the metabolic syndrome in Type 2 diabetes: the Prospective Evaluation of Diabetic Ischaemic Heart Disease by Coronary Tomography (PREDICT) Study. Diabet Med 2006 0.78
49 Hypertriglyceridaemia and hyperuricaemia. Lancet 1977 0.77
50 Treatment of diabetes: the effect on serum lipids and lipoproteins. Postgrad Med J 1991 0.77
51 Analysis of high density lipoprotein subclasses by a precipitation procedure: comparison with preparative ultracentrifuge. Clin Chim Acta 1982 0.77
52 Aspects of metabolism in normal and gestational diabetic pregnancy. Biochem Soc Trans 1995 0.77
53 Serum insulin, glucose, and lipid levels among mild diabetics in relation to incidence of vascular complications. Lancet 1971 0.77
54 Determinants of mild fasting hypertriglyceridaemia in non-insulin-dependent diabetes. J Intern Med 1991 0.76
55 Serum lipids and apolipoproteins and their relationship with macrovascular disease in type 1 diabetes. Diabet Med 1994 0.76
56 Reduced postprandial energy expenditure in women predisposed to type 2 diabetes. Diabet Med 1994 0.76
57 Ethnic differences in insulin secretion in women at risk of future diabetes. Diabet Med 1992 0.76
58 Abnormalities in fasting circulating proinsulin concentration in mild gestational diabetes. Clin Endocrinol (Oxf) 1991 0.76
59 Feedback inhibition of insulin secretion in type 2 diabetes. Clin Sci (Lond) 1991 0.76
60 The reduction of low density lipoprotein cholesterol by metformin is maintained with long-term therapy. J R Soc Med 1989 0.76
61 A defect in insulin release in women at risk of future non-insulin-dependent diabetes. Clin Sci (Lond) 1991 0.76
62 Regulation of hepatic lipase expression in HepG2 cells. Biochem Soc Trans 1997 0.76
63 Chlorpropamide lowers serum and lipoprotein cholesterol in insulin-dependent diabetes. Diabet Med 1986 0.76
64 Blood glucose and coronary heart disease. Eur Heart J 2000 0.75
65 The value of screening for diabetes in patients with skin sepsis. J R Soc Med 1993 0.75
66 The secretion of thyrotrophin with impaired biological activity in patients with hypothalamic-pituitary disease. Clin Endocrinol (Oxf) 1978 0.75
67 Haemoglobin A1, blood glucose, and high-density lipoprotein cholesterol in insulin-requiring diabetics. Lancet 1978 0.75
68 Hypertriglyceridaemia and abdominal pain. Br Med J 1976 0.75
69 The effect of CI-719 on lipolysis in rat adipose tissue. Proc R Soc Med 1976 0.75
70 Attitude of consultant physicians to Calman proposals. Anxieties are widespread. BMJ 1996 0.75
71 Insulin resistance, cardiovascular risk factors and ultrasonically measured early arterial disease in normotensive Type 2 diabetic subjects. Diabetes Metab Res Rev 2001 0.75
72 Solitary pancreas transplantation. Diabetologia 1997 0.75
73 Insulin and atheroma. Lancet 1969 0.75
74 Acute lipoprotein changes associated with atenolol therapy for hypertension in non-insulin dependent diabetes. J Hum Hypertens 1988 0.75
75 The effect of treatment of non-insulin-dependent diabetes mellitus (NIDDM) on serum lipids and lipoproteins. Q J Med 1989 0.75
76 Type 1 diabetes and ageing: does LDL oxidation mediate their associations with coronary heart disease? Eur Heart J 2001 0.75
77 Experimental hypertriglyceridaemia and plasma PHLA in man. Horm Metab Res 1978 0.75
78 Lipoprotein lipase in human adipose tissue. Clin Sci 1973 0.75
79 The role of heparin in lipoprotein lipase activity. Horm Metab Res 1974 0.75
80 Hepatic abscess in a diabetic patient. Postgrad Med J 2000 0.75
81 Proceedings: Plasma cyclic AMP response to glucagon in thyroid disease. Clin Sci Mol Med 1974 0.75
82 Glucagon resistance as a case of hypertriglyceridaemia. Lancet 1976 0.75
83 The response of hepatic lipase and serum lipoproteins to acute hyperinsulinaemia in type 2 diabetes. Eur J Clin Invest 1992 0.75
84 Effect of storage on the precipitation procedure for the measurement of HDL subclasses in serum. Clin Chim Acta 1984 0.75
85 Comparison between oral and intravenous fat tolerance tests in normolipidaemic subjects. Horm Metab Res 1988 0.75
86 Long term improvement in dyslipidaemia in Type 2 diabetes with bezafibrate is not related to changes in insulin resistance. Atherosclerosis 1999 0.75
87 Necrobiosis lipoidica in two diabetic sisters. Clin Exp Dermatol 1985 0.75
88 The effects of glibenclamide on glucose homeostasis and lipoprotein metabolism in poorly controlled type 2 diabetes. Horm Metab Res 1993 0.75
89 The influence of regional adiposity on atherogenic risk factors in men and women with type 2 diabetes. Diabet Med 1991 0.75
90 The effect of insulin treatment on the metabolic response to glucagon in diabetes. Diabete Metab 1977 0.75
91 Therapy and clinical trials. Curr Opin Lipidol 1998 0.75
92 Diabetic macrovascular disease and serum lipids: is there a connection? Diabet Med 1992 0.75
93 High density lipoprotein subfraction cholesterol in hypertriglyceridaemia. Atherosclerosis 1982 0.75
94 Plasma cyclic AMP response to glucagon as an index of tissue responsiveness to thyroid hormone. Diabete Metab 1978 0.75
95 Post-heparin lipolytic activity and tissue lipoprotein lipase activity in the alloxan-diabetic rat. Clin Sci Mol Med 1974 0.75
96 Association of high density lipoprotein cholesterol with plasma lipolytic activity and C-peptide concentration in type 2 diabetes. Diabetes Res 1991 0.75
97 The direct effect of oral hypoglycaemic agents on glucose metabolism by adipose tissue. Horm Metab Res 1972 0.75
98 Therapy and clinical trials. Curr Opin Lipidol 1999 0.75
99 Insulin, glucose and lipid levels in mild diabetics in relation to complications. Adv Metab Disord 1973 0.75
100 Low energy diets in the treatment of gestational diabetes. Acta Endocrinol Suppl (Copenh) 1986 0.75
101 Comparison of the progress of flat new vessels on the optic disc with those on the retina in patients treated by pituitary ablation. Diabetologia 1971 0.75
102 The long-term effects of chlorpropamide on insulin, C-peptide, and proinsulin secretion. Diabetes Care 1983 0.75
103 Bimonthly update. Therapy and clinical trials. Curr Opin Lipidol 2000 0.75
104 The contribution of hepatic triglyceride lipase to plasma post-heparin lipolytic activity in the rat. Horm Metab Res 1977 0.75
105 Diabetes and therapy with potent diuretics. Lancet 1978 0.75